Conference abstractPublished 6 Oct 2015
Anti-biofilm compounds from bacterial in situ growth bacteria
1Ben-Gurion University of the Negev, Israel 2Nanyang Technological University, Singapore
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The development of multiple drug resistance has risen spectacularly in the last decades and presently threatens medicine as we know it today. Bacterial communities in biofilm state are more protected from the hostâÂ?Â?s immune system and may be more tolerant to antibiotics, sometimes up to 1000 times when compared to these communities in the planktonic state. Biofilms develop via a process known as Quorum Sensing (QS), an inter-bacterial communication pathway. Therefore, one possible and promising venue for the development novel antibacterials is via disruption of this communication pathway. QS-inhibition may thus act on certain bacterial populations without affecting their growth, minimizing the selective pressure, and not imposing selective pressures leading to resistance. The search for novel QS inhibitors is underway in particular in a variety of samples from a number of environments, including soil and marine environments. Herein, we present a novel technique for in situ bacterial culture and screening for QSinhibitors from the coral reef environment. Coral mucus associated bacteria are entrapped inside spheres that enable mass transfer. This allows the study of uncultured and unknown bacteria many of which were only studied to a limited extent. These bacteria containing spheres provide a platform for the isolation of previously-uncultured species. Screening of their potential as QS inhibitors was carried out by developing a new medium that stimulated QS-inhibitor production. The spheresâÂ?Â? bacterial consortia that were active were then analyzed molecularly. Further screenings revealed one highly active anti-biofilm compound whose structure is currently being elucidated.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hilla Ben-Hamo”
- BylineArticles whose byline prints “Shimrit Laor”
- BylineArticles whose byline prints “Hadar Avidor”
- BylineArticles whose byline prints “Robert S Marks”
- BylineArticles whose byline prints “Ariel Kushmaro”